News

Deal Announcements

Achaogen Closes $56 Million Venture Capital Funding

Friday, April 9, 2010 5:28:00 AM PDT | VentureDeal Staff
South San Francisco, California  --  Biotechnology company Achaogen has raised $56 million in its third round of institutional venture capital investment.

Achaogen is developing a pipeline of life-saving antibiotics, including a lead candidate for multi-drug-resistant bacterial infections.

Frazier Healthcare Ventures led the round, which included numerous top-tier venture capital firms.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1